Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis
- PMID: 6660863
- PMCID: PMC185414
- DOI: 10.1128/AAC.24.6.950
Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis
Abstract
After a single 500-mg intravenous dose of metronidazole, plasma and dialysate levels were measured over a 7.5-h period in five patients undergoing peritoneal dialysis for terminal renal failure. Approximately 10% of this dose was removed by dialysis during that period, and therapeutic levels were maintained in plasma. No routine adjustment in the dosage of metronidazole appears necessary in patients undergoing peritoneal dialysis.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
